Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer.

Wu YL, Hochmair M, Yang Y, Yang XN, Tsuboi M, Paz-Ares L, Yang JC, Wu L, Kim HR, Rieke DT, Johnson M, Besse B, Sharma N, Maeda P, Peterson P, Lin BK, Frimodt-Moller B, Goldman J, Drilon A, LIBRETTO-432 Trial Investigators

Open source

DOI: 10.1056/nejmoa2602628
Published: 2026 Aug 13
Container: The New England journal of medicine
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1056/nejmoa2602628,
  title = {Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer.},
  author = {Wu YL and Hochmair M and Yang Y and Yang XN and Tsuboi M and Paz-Ares L and Yang JC and Wu L and Kim HR and Rieke DT and Johnson M and Besse B and Sharma N and Maeda P and Peterson P and Lin BK and Frimodt-Moller B and Goldman J and Drilon A and LIBRETTO-432 Trial Investigators},
  year = {2026},
  journal = {The New England journal of medicine},
  doi = {10.1056/nejmoa2602628},
  url = {https://doi.org/10.1056/nejmoa2602628}
}

RIS

TY  - JOUR
TI  - Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer.
AU  - Wu YL
AU  - Hochmair M
AU  - Yang Y
AU  - Yang XN
AU  - Tsuboi M
AU  - Paz-Ares L
AU  - Yang JC
AU  - Wu L
AU  - Kim HR
AU  - Rieke DT
AU  - Johnson M
AU  - Besse B
AU  - Sharma N
AU  - Maeda P
AU  - Peterson P
AU  - Lin BK
AU  - Frimodt-Moller B
AU  - Goldman J
AU  - Drilon A
AU  - LIBRETTO-432 Trial Investigators
PY  - 2026
JO  - The New England journal of medicine
DO  - 10.1056/nejmoa2602628
UR  - https://doi.org/10.1056/nejmoa2602628
ER  -

APA

YL, W., M, H., Y, Y., XN, Y., M, T., L, P., JC, Y., L, W., HR, K., DT, R., M, J., B, B., N, S., P, M., P, P., BK, L., B, F., J, G., A, D., & Investigators, L. T. (2026). Selpercatinib in Early-Stage RET Fusion-Positive Non-Small-Cell Lung Cancer.. The New England journal of medicine. https://doi.org/10.1056/nejmoa2602628

Source records

pubmed · retrieved 2026-09-25T10:21:04.970Z